What is YPlasma?
YPlasma, a spin-off from INTA, is at the forefront of developing advanced plasma actuators designed for precise ionic flow control. The company's innovative technology has a wide array of applications, including deicing, cooling, disinfection, aerodynamics, and electro-stimulation. These capabilities position YPlasma to make substantial impacts across diverse sectors such as Energy, Automotive, Aerospace, Electronics, Agriculture, and Health, signaling a strong market presence and a versatile technological foundation.
How much funding has YPlasma raised?
YPlasma has raised a total of $2.5M across 1 funding round:
Seed
$2.5M
Seed (2025): $2.5M with participation from Faber and SOSV
Key Investors in YPlasma
Faber
Faber is an early-stage venture capital firm specializing in frontier technology and deep tech, primarily investing in Southern Europe. They support companies from pre-seed to Series A stages, focusing on applied science and digital transformation.
SOSV
SOSV is a multi-stage venture capital investor that provides both intellectual and financial capital to accelerate the growth of innovative companies.
What's next for YPlasma?
The recent major strategic investment provides YPlasma with substantial resources to accelerate its growth and expand its technological reach. This capital infusion is expected to fuel further research and development, enhance manufacturing capabilities, and drive market penetration across its target industries. YPlasma's focus on advanced plasma actuator technology suggests a trajectory towards becoming a key player in sectors requiring precise environmental control and advanced aerodynamic solutions.
See full YPlasma company page
